Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical products-Reference-Cited by-同舟云学术

Good Manufacturing Practice–compliant human induced pluripotent stem cells: from bench to putative clinical products

Published:2024-06 Issue:6 Volume:26 Page:556-566
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Novoa Juan J.^ORCID,Westra Inge M.,Steeneveld Esther^ORCID,Fonseca Neves Natascha^ORCID,Arendzen Christiaan H.^ORCID,Rajaei Bahareh,Grundeken Esmée,Yildiz Mehmet^ORCID,van der Valk Wouter^ORCID,Salvador Alison^ORCID,Carlotti Françoise^ORCID,Dijkers Pascale F.^ORCID,Locher Heiko^ORCID,van den Berg Cathelijne W.^ORCID,Raymond Karine I.^ORCID,Kirkeby Agnete^ORCID,Mummery Christine L.^ORCID,Rabelink Ton J.^ORCID,Freund Christian,Meij Pauline^ORCID,Wieles Brigitte^ORCID

Funder

Novo Nordisk Foundation

Publisher

Elsevier BV

Reference40 articles.

1. Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease;Schweitzer;N Engl J Med,2020

2. Autologous induced stem-cell-derived retinal cells for macular degeneration;Mandai;N Engl J Med,2017

3. Applications of iPSC-derived beta cells from patients with diabetes;Maxwell;Cell Rep Med,2021

4. Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study;Bloor;Nat Med,2020

5. European Commission, EudraLex - EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, vol. 4. [Online], ; 2010 [accessed 07.09.2023].

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating human induced pluripotent stem cell-specific quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system;Cytotherapy;2024-09

2. Advancements and challenges in stem cell transplantation for regenerative medicine;Heliyon;2024-08

3. Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes;Transplant International;2024-07-26